Related Experiment Video
Updated: Jun 26, 2026

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
[Long-term low molecular weight heparin protection during pregnancy for the recurrent fetal loss]
Z Hajsmanová1, J Slechtová, P Sigutová
1Hematologický úsek, UKBH FN a LF UK, Plzen. hajsmanova@fnplzen.cz
Abstract:
Recurrent fetal loss affects 1 to 5% women of the fertile age all over the world. Pathogenesis of recurrent early or late fetal loss remains unclear and therefore the LMHW administration during pregnancy has not been sorted out so far. Our trial deals with a cohort of 51 pregnant women with recurrent fetal loss in their personal history treated by long-term administration of LMWHs which was compared with a cohort of healthy women LMWHs untreated. 91% effectiveness of a long-term LMWH protection means in fact 43 liveborn babies delivered without any complications during pregnancy and delivery to 47 women - 30 of these women were primiparas.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Teratogenicity
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...